Closed Incision Negative Pressure Wound Therapy vs. Foam as Post Operative Dressing
-
- STATUS
- Recruiting
-
- days left to enroll
- 13
-
- participants needed
- 60
-
- sponsor
- Icahn School of Medicine at Mount Sinai
Summary
The primary objective is to assess the frequency of a wound healing complication, in a closed incisional wound in a "high risk" surgical incision when treated with Negative Pressure Wound Therapy versus a highly absorbent antimicrobial post - operative absorbent dressing.
Description
A healing complication is defined as presence of at least one of the following conditions: infection (superficial or deep), dehiscence (partial, superficial, or deep), or delayed healing (incision not 100% closed within 7 days of the first surgical procedure), drainage form the wound after 96 hours post operatively.
The secondary objectives are to assess any changes in the following assessments of the surgical incision weekly over the treatment period:
- Surrounding skin condition
- Incision complications, infection or clinical signs of infection
- to assess the number and type of these complications individually including other postsurgical complications: skin necrosis, cellulitis, abscess, suture abscess, seroma, periwound edema or hematoma occurring within 21, 42, and 90 days postoperatively
- Pain during dressing changes
Assessment of the following at dressing changes:
- Duration/wear time
- Ease of use; difficulty with sleep
- Damage to surrounding skin on removal
- Assessment of re-epithelialization/closure
- Patient comfort during wear; ease of ambulation
- Conformability of dressing
- Exudate management
- Reasons for removal
To assess the overall comparison of Avance® Solo to the standard of care foam dressing.
Details
| Condition | High Risk Surgical Incisions |
|---|---|
| Treatment | Avance Solo, Optifoam |
| Clinical Study Identifier | NCT05427916 |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Modified on | 14 July 2022 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer